Biofrontera Inc reports results for the quarter ended in December - Earnings Summary

Biofrontera

15/03/2024 23:10

* Biofrontera Inc  BFRI.OQ  reported a quarterly adjusted
loss of
$1.80​​ per share for the quarter ended in December, higher than
the same quarter last year, when the company reported EPS of
$-2.80.  The mean expectation of two analysts for the quarter
was for a loss of $1.19 per share. Wall Street expected
results to range from $-1.53 to -85 cents per share.
    * Revenue rose 4.5% to $10.60 million from a year ago;
analysts
expected $11.52 million. 
    * Biofrontera Inc's reported EPS for the quarter was $1.65​.
    * The company reported quarterly net income of $3.53
million.
    * Biofrontera Inc shares had fallen by 36.8% this quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 21.4%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Biofrontera Inc
is $16.00 
This summary was machine generated from LSEG data March 15 at
11:09 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -1.19          -1.80          Missed
 Sep. 30 2023      -3.78          -4.64          Missed
 Jun. 30 2023      -4.61          -7.23          Missed
 Mar. 31 2023      -3.90          -5.60          Missed